The Home INR Study (THINRS)
CSP #481 - The Home INR Study (THINRS)
연구 개요
상태
정황
상세 설명
Intervention: Weekly patient self-testing (PST) of prothrombin time by international normalized ratio (PT INR) versus conventional monthly high quality anticoagulation management (HQACM) from an anticoagulation clinic with a minimum two years follow-up.
Primary Hypothesis: Compared to conventional monitoring in the clinic, PST of anticoagulation intensity will decrease the number of events of thromboembolism (strokes), bleeding, and all cause deaths and improve the quality of anticoagulation.
Second Hypothesis: PST and conventional monitoring will be comparable in terms of health care utilization and cost.
Primary Outcomes: Event rates (thromboembolism or bleeding episodes), time to first event, time within therapeutic range for anticoagulation intensity, and total health care cost (including price of PST monitors) and utilization.
Study Abstract: Since home monitors of prothrombin time (PT) may potentially improve the safety, quality, and convenience of chronic anticoagulation management, it is likely that there will be demands from providers, patients, and manufacturers to make home monitors available to VA patients. The rationale for PST is that it would permit more intense monitoring and increased patient participation in his/her own care, resulting in increased precision in anticoagulation control and thus fewer events.
Original plan was for a study at 32 sites with a total sample size of about 3,200 patients and a length of three years (one for recruitment and two years of follow-up). Final status was 28 sites that randomized 2922 patients in 2.75 years of recruitment with a minimum of two years of follow-up.
연구 유형
등록 (실제)
단계
- 4단계
연락처 및 위치
연구 장소
-
-
Alabama
-
Birmingham, Alabama, 미국, 35233
- VA Medical Center, Birmingham
-
-
California
-
Fresno, California, 미국, 93703
- VA Central California Health Care System, Fresno
-
Loma Linda, California, 미국, 92357
- VA Medical Center, Loma Linda
-
Palo Alto, California, 미국, 94304-1290
- VA Palo Alto Health Care System
-
West Los Angeles, California, 미국, 90073
- VA Greater Los Angeles Healthcare System, West LA
-
-
Colorado
-
Denver, Colorado, 미국, 80220
- VA Eastern Colorado Health Care System, Denver
-
-
Connecticut
-
West Haven, Connecticut, 미국, 06516
- VA Connecticut Health Care System (West Haven)
-
-
Illinois
-
Hines, Illinois, 미국, 60141-5000
- Edward Hines, Jr. VA Hospital
-
North Chicago, Illinois, 미국, 60064
- VA Medical Center, North Chicago
-
-
Iowa
-
Iowa City, Iowa, 미국, 52246-2208
- VA Medical Center, Iowa City
-
-
Maryland
-
Baltimore, Maryland, 미국, 21201
- VA Maryland Health Care System, Baltimore
-
-
Michigan
-
Detroit, Michigan, 미국, 48201
- John D. Dingell VA Medical Center, Detroit
-
-
Minnesota
-
Minneapolis, Minnesota, 미국, 55417
- VA Medical Center, Minneapolis
-
-
Missouri
-
Kansas City, Missouri, 미국, 64128
- VA Medical Center, Kansas City MO
-
-
Nevada
-
North Las Vegas, Nevada, 미국, 89036
- Las Vegas
-
Reno, Nevada, 미국, 89502
- VA Sierra Nevada Health Care System
-
-
New York
-
Bronx, New York, 미국, 10468
- VA Medical Center, Bronx
-
Buffalo, New York, 미국, 14215
- VA Western New York Healthcare System at Buffalo
-
Syracuse, New York, 미국, 13210
- VA Medical Center, Syracuse
-
-
North Carolina
-
Durham, North Carolina, 미국, 27705
- Durham VA Medical Center HSR&D COE
-
-
Ohio
-
Cleveland, Ohio, 미국, 44106
- VA Medical Center, Cleveland
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73104
- VA Medical Center, Oklahoma City
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, 미국, 15240
- VA Pittsburgh Health Care System
-
-
Rhode Island
-
Providence, Rhode Island, 미국, 02908
- VA Medical Center, Providence
-
-
Texas
-
Dallas, Texas, 미국, 75216
- VA North Texas Health Care System, Dallas
-
San Antonio, Texas, 미국, 78229
- VA South Texas Health Care System, San Antonio
-
-
Virginia
-
Salem, Virginia, 미국, 24153
- VA Medical Center, Salem VA
-
-
Wisconsin
-
Madison, Wisconsin, 미국, 53705
- Wlliam S. Middleton Memorial Veterans Hospital, Madison
-
-
-
-
-
San Juan, 푸에르토 리코, 00921
- VA Medical Center, San Juan
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
To be enrolled in this study, patients must:
- have AF and/or a MHV;
- be scheduled to receive warfarin indefinitely (operationally defined as 2 years);
- be using warfarin according to the criteria described in the Coumadin package insert (no off-label uses);
- be expected to survive for the duration of the study;
- not be suffering from intracranial bleeding (intracranial hemorrhage, subarachnoid hemorrhage, hemorrhagic stroke) or any other contraindication described in the Coumadin package insert;
- be willing to perform PST;
- be willing to be randomized;
- possess adequate cognitive and language skills to follow the protocol and all related instructions;
- be willing to participate for the full duration of the study;
- sign the informed consent form; and
- not be enrolled in another randomized clinical trial that involves a drug or device intervention.
Exclusion Criteria:
Patients are excluded in this study if:
- subject has had intracranial hemorrhage, subarachnoid hemorrhage, hemorrhagic stroke, or any other absolute/major contraindication described in the warfarin package insert within the last month
- subject enrolled in another randomized clinical trial that involves a drug or device intervention
- subject is not able to follow the protocol and all related instructions, and does not have a caregiver with these skills
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Arm 1
Patient Self-Testing (PST) of prothrombin time by international normalized ratio (PT-INR or INR) with weekly testing
|
|
|
다른: Arm 2
High quality anticoagulation management (HQACM) with conventional monthly testing
|
HQACM with testing every 4 weeks and as indicated for out of range values, medication/clinical changes.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Time to First Event (Death, Stroke, Major Bleed)
기간: Time to event
|
Time to first event (death, stroke, major bleed) The primary outcome was time to first event, and we used the Kaplan-Meier method to compare survival curves and the results using the log-rank test. The number of patients with a primary outcome is what was reported in the NEJM paper. Below is the unpublished cumulative incidence information. |
Time to event
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Time in Therapeutic Range Over Full Length of Follow-up (0 to 100 Percent)
기간: Full length of follow-up; average of 3 years
|
Time in target range (TTR) based on Prothrombin Time standardized to the International Normalized Ratio
|
Full length of follow-up; average of 3 years
|
|
DASS at 2 Years of Follow-up
기간: At two years of follow-up
|
Satisfaction with care was quantified using the Duke Anticoagulation Satisfaction Scale (DASS).
Scores range from 25 to 225, with lower scores indicating higher satisfaction.
|
At two years of follow-up
|
|
Cumulative Gain in Health Utilities at 2 Year
기간: After 2 years of follow-up for each subject
|
Scores range from -0.36 to 1.00 per year, with a negative score indicating a state worse than being dead and a score of 1.00 indicating perfect health.
Since the time frame is 2 years, the range is -0.72 to 2.00.
|
After 2 years of follow-up for each subject
|
|
Health Care Costs at 2 Year
기간: After 2 years of follow-up for each subject
|
After 2 years of follow-up for each subject
|
공동 작업자 및 조사자
수사관
- 연구 의자: David B. Matchar, MD, Durham VA Medical Center HSR&D COE
간행물 및 유용한 링크
일반 간행물
- Dolor RJ, Ruybalid RL, Uyeda L, Edson RG, Phibbs C, Vertrees JE, Shih MC, Jacobson AK, Matchar DB; THINRS Site Investigators. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS). J Thromb Thrombolysis. 2010 Oct;30(3):263-75. doi: 10.1007/s11239-010-0499-8.
- Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, Vertrees JE, Shih MC, Holodniy M, Lavori P; THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010 Oct 21;363(17):1608-20. doi: 10.1056/NEJMoa1002617. Erratum In: N Engl J Med. 2011 Jan 6;364(1):93.
- Matchar DB, Jacobson AK, Edson RG, Lavori PW, Ansell JE, Ezekowitz MD, Rickles F, Fiore L, Boardman K, Phibbs C, Fihn SD, Vertrees JE, Dolor R. The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS). J Thromb Thrombolysis. 2005 Jun;19(3):163-72. doi: 10.1007/s11239-005-1452-0.
- Phibbs CS, Love SR, Jacobson AK, Edson R, Su P, Uyeda L, Matchar DB; writing for the THINRS Executive Committee and Site Investigators. At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS). J Gen Intern Med. 2016 Sep;31(9):1061-7. doi: 10.1007/s11606-016-3700-8. Epub 2016 May 27.
- Matchar DB, Love SR, Jacobson AK, Edson R, Uyeda L, Phibbs CS, Dolor RJ. The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial. J Thromb Thrombolysis. 2015 Jul;40(1):17-25. doi: 10.1007/s11239-014-1128-8.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
심방세동에 대한 임상 시험
-
Assistance Publique - Hôpitaux de Paris아직 모집하지 않음과도한 Supraventricular Ectopies 또는 Short Atrial Runs(ESVEA)
-
University of Pennsylvania빼는전형적인 심방 조동 | Atrial Flutter의 향후 개발 위험 요소미국